Search research articles
Contact Us
Filters
Showing results (31-40 of 53) with videos related to
Page
of 6
Sort By:
Molecular and Cellular Biology
|
March 6, 1998
The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent
L Whitesell, P D Sutphin, E J Pulcini, et al.
Pediatric Nephrology (Berlin, Germany)
|
February 2, 2000
Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration
P D Yorgin, D K Eklund, A al-Uzri, et al.
Oncogene
|
June 12, 1997
Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo
L Whitesell, P Sutphin, W G An, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2001
Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer
R Bagatell, O Khan, G Paine-Murrieta, et al.
The American Journal of Medicine
|
April 27, 1987
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin
N K Henry, M S Rouse, A L Whitesell, et al.
European Cytokine Network
|
March 1, 1992
Detection of functional interferon alpha receptors in human neuroendocrine tumor cell lines using a new monoclonal antibody
A Rosolen, O R Colamonici, L M Pfeffer, et al.
The Mental Health Clinician
|
July 28, 2021
Safety of ECT in patients receiving an oral anticoagulant
Nicolette R Centanni, Wendy Y Craig, Dena L Whitesell, et al.
Molecular and Cellular Biology
|
December 1, 1995
Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent
D F Smith, L Whitesell, S C Nair, et al.
Developmental Biology
|
June 12, 1999
Disruption of zebrafish somite development by pharmacologic inhibition of Hsp90
Z Lele, S D Hartson, C C Martin, et al.
Cancer Immunology, Immunotherapy : CII
|
April 24, 2001
Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice
L He, H Feng, A Raymond, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 53) with videos related to
Sort By:
Page
of 6
Molecular and Cellular Biology
|
March 6, 1998
The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent
L Whitesell, P D Sutphin, E J Pulcini, et al.
Pediatric Nephrology (Berlin, Germany)
|
February 2, 2000
Concurrent centrifugation plasmapheresis and continuous venovenous hemodiafiltration
P D Yorgin, D K Eklund, A al-Uzri, et al.
Oncogene
|
June 12, 1997
Geldanamycin-stimulated destabilization of mutated p53 is mediated by the proteasome in vivo
L Whitesell, P Sutphin, W G An, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2001
Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer
R Bagatell, O Khan, G Paine-Murrieta, et al.
The American Journal of Medicine
|
April 27, 1987
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin
N K Henry, M S Rouse, A L Whitesell, et al.
European Cytokine Network
|
March 1, 1992
Detection of functional interferon alpha receptors in human neuroendocrine tumor cell lines using a new monoclonal antibody
A Rosolen, O R Colamonici, L M Pfeffer, et al.
The Mental Health Clinician
|
July 28, 2021
Safety of ECT in patients receiving an oral anticoagulant
Nicolette R Centanni, Wendy Y Craig, Dena L Whitesell, et al.
Molecular and Cellular Biology
|
December 1, 1995
Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent
D F Smith, L Whitesell, S C Nair, et al.
Developmental Biology
|
June 12, 1999
Disruption of zebrafish somite development by pharmacologic inhibition of Hsp90
Z Lele, S D Hartson, C C Martin, et al.
Cancer Immunology, Immunotherapy : CII
|
April 24, 2001
Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice
L He, H Feng, A Raymond, et al.
Page
of 6